Apollon Wealth Management, LLC Astrazeneca PLC Transaction History
Apollon Wealth Management, LLC
- $4.22 Billion
- Q4 2024
A detailed history of Apollon Wealth Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Apollon Wealth Management, LLC holds 15,796 shares of AZN stock, worth $1.12 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
15,796
Previous 15,449
2.25%
Holding current value
$1.12 Million
Previous $1.2 Million
14.05%
% of portfolio
0.02%
Previous 0.03%
Shares
16 transactions
Others Institutions Holding AZN
# of Institutions
1,336Shares Held
477MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.46 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.98 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.64 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.61 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.36 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $220B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...